Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Vadim Divilov"'
Autor:
Jason P Holland, Eloisi Caldas-Lopes, Vadim Divilov, Valerie A Longo, Tony Taldone, Danuta Zatorska, Gabriela Chiosis, Jason S Lewis
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8859 (2010)
The positron-emitting radionuclide (89)Zr (t(1/2) = 3.17 days) was used to prepare (89)Zr-radiolabeled trastuzumab for use as a radiotracer for characterizing HER2/neu-positive breast tumors. In addition, pharmacodynamic studies on HER2/neu expressio
Externí odkaz:
https://doaj.org/article/2b4fe11be30f436baa1d26b56108628c
Publikováno v:
Gastroenterology Research
Background There are validated clinical risk scores for risk stratifying patients presenting with acute upper gastrointestinal bleed (GIB), including Glasgow-Blatchford score (GBS), Pre-endoscopic Rockall score (RS-PE) and post-endoscopic complete Ro
Autor:
Nagavarakishore Pillarsetty, Jason S. Lewis, Vadim Divilov, Jacek Koziorowski, Kim Francis Andersen
Publikováno v:
Nuclear Medicine and Biology. 40:524-528
The antilipolytic drug Acipimox reduces free fatty acid (FFA) levels in the blood stream. We examined the effect of reduced FFAs on glucose metabolism in androgen-dependent (CWR22Rv1) and androgen-independent (PC3) prostate cancer (PCa) xenografts.Su
Publikováno v:
American Journal of Gastroenterology. 113:S552
Autor:
Steven M. Larson, Jason P. Holland, Neil H. Bander, Vadim Divilov, Jason S. Lewis, Peter Smith-Jones
Publikováno v:
Journal of Nuclear Medicine. 51:1293-1300
89Zr (half-life, 78.41 h) is a positron-emitting radionuclide that displays excellent potential for use in the design and synthesis of radioimmunoconjugates for immunoPET. In the current study, we report the preparation of 89Zr-desferrioxamine B (DFO
Publikováno v:
Gastroenterology. 154:S-888
Publikováno v:
American Journal of Gastroenterology. 112:S1408
Autor:
Nagavarakishore Pillarsetty, Vadim Divilov, Nicholas Ramos, Jason S. Lewis, Brian M. Zeglis, Pierre Daumar, Kuntal K. Sevak
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2014, 86, pp.769-781. ⟨10.1016/j.ejmech.2014.09.019⟩
European Journal of Medicinal Chemistry, Elsevier, 2014, 86, pp.769-781. ⟨10.1016/j.ejmech.2014.09.019⟩
Type II topoisomerase (Topo-II) is an ATP-dependent enzyme that is essential in the transcription, replication, and chromosome segregation processes and, as such, represents an attractive target for cancer therapy. Numerous studies indicate that the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4402b04154e212dd1b866b3169a1e2a
https://hal.archives-ouvertes.fr/hal-03121843
https://hal.archives-ouvertes.fr/hal-03121843
Autor:
Ronald G. Blasberg, Kuntal K. Sevak, Oleg A. Andreev, Michael Anderson, Ellen Ackerstaff, Yana K. Reshetnyak, Donald M. Engelman, Inna Serganova, Nerissa Viola-Villegas, Natalia Kruchevsky, Jason S. Lewis, Vadim Divilov, Sean Carlin, Jason A. Koutcher
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 111(20)
Generally, solid tumors (400 mm(3)) are inherently acidic, with more aggressive growth producing greater acidity. If the acidity could be targeted as a biomarker, it would provide a means to gauge the pace of tumor growth and degree of invasiveness,
Autor:
Jason S. Lewis, Kuntalkumar Sevak, Nagavarakishore Pillarsetty, Jacek Koziorowski, Vadim Divilov, Kim Francis Andersen
The study focuses on the interaction between glucose and free fatty acids (FFA) in malignant human prostate cancer cell lines by an in vitro observation of uptake of fluoro-2-deoxy-D-glucose (FDG) and acetate.Human prostate cancer cell lines (PC3, CW
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7a11b15db631d00040087d80cb33cfe
https://europepmc.org/articles/PMC4959437/
https://europepmc.org/articles/PMC4959437/